Background: Drug or substance abuse reefers to the use of illicit (illegal) drugs and to the misuse of prescription or over-the-counter drugs. It is recognized as a serious risk to the health and safety of the user. Screening for substance abuse in workers is very important in the field of prevention and management of the problem of drug abuse. Objectives: This work aims at studying drug abuse among workers admitted to Menoufiya Poisoning and Addiction Control Center to illustrate the socio-demographic data of the drug abusers, the prevalence of drug abuse in different occupations and the impact of drug abuse on health and work. Methods: A total of seventy six worker patients admitted to Menoufiya Poisoning and Addiction Control Center throughout the year 2007 (out off the total number of admitted patients) were included in this study. The control group comprised one hundred and fifty two matching male subjects not known to be drug abusers. They were selected from volunteer blood donors in Menoufiya University blood bank. The studied population was divided according to occupation into professionals, skilled and unskilled workers. All participants were subjected to a predesigned questionnaire stressing on circumstances of drug abuse, clinical examination and investigations including chest x-ray, ECG, blood analysis for serum hepatitis B surface antigen (HBsAg) and hepatitis C antibodies (HCAb). Results: Most of the studied individuals were skilled workers (46 persons, 60.5%), followed by unskilled ones (22 persons, 28.9%) and the least were professionals (8 persons, 10.6%). Skilled workers had a significantly higher prevalence of basic education than the others, working more than 12 hours/day at night shifts and living in families of more than three members. Trial was the main cause of drug abuse, friends were the persuading personsnel, pharmacies were the most prevalent sources of getting drugs and mixed types of drugs were taken by oral route during work shifts. Moreover, hepatitis C antibodies and abnormal
Background: Acute coronary syndrome (ACS) refers to a spectrum of symptoms compatible with acute myocardial ischemia. Worldwide acute coronary syndrome (ACS) is one of the main reasons for hospital admission and the leading cause of death. Several risk factors have been identified. However high blood pressure and hypercholesterolemia remain the most important risk factors in (ACS). Objective: To determine the risk factors associated with ACS among patients admitted to the coronary care unit (CCU) in the Military Hospital-Sana'a. Methodology: Study design according to a case-control study. Two groups of patients were included in this study, the first group was cases who have (ACS), and the second group was control cases admitted to CCU for other causes. All data were recorded in a special sheet including demographic, clinical presentation, investigation, and treatment plan. The data was entered into PC and analyzed statistically. Results: There were 124 patients with ACS versus 91 control patients without ACS. The majority of participants in the two groups were males (80 %). Their age ranged from 18 to 95 years old with a mean age of 53.9 ±13.6 years. (86.5 %) of them were 40 years old or above. The significant risk factors associated with ACS were hypertension, Khat chewing found in 71.6 %, 64.4%, of the patients, respectively. Another significant risk factor was dyslipidemia which was higher among ACS patients than the control group with a P-value of < 0.05.
Conclusion:Preventing the program from avoiding risk factors that were associated with ACS may decrease the occurring of ACS and reduce the morbidity and mortality in Yemeni patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.